Skip to content

Fuel Selection During Eccentric Cycling With Glucose Ingestion

Fuel Selection During Eccentric Cycling: Comparison With Concentric Cycling and the Effect of Glucose Ingestion During Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03995693
Enrollment
75
Registered
2019-06-24
Start date
2019-08-01
Completion date
2021-12-01
Last updated
2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Damage Muscle, Nutrition

Keywords

eccentric exercise, 13C-glucose, exercise mode

Brief summary

This study compares fuel selection during eccentric and concentric cycling, with (placebo) or without glucose ingestion during exercise. After a 2-week familiarization and habituation with the ergometers, subjects will complete four experimental conditions in a randomized order: concentric with placebo, eccentric with placebo, concentric with glucose, eccentric with glucose.

Detailed description

Cycling on a cycle ergometer typically requires repeated concentric muscle contractions to push on the pedals and produce mechanical work. An eccentric cycling ergometer has a motor that rotates the cranks with a predetermined torque, the cyclist needs to resist to the movement of the cranks. This leads to eccentric muscle contractions, the work is thus produced while the muscle is lengthening (negative work). This mode of exercise is known to produce a lower oxygen consumption (energy cost) for the same mechanical power output and also leads to muscle damage which can interfere with fuel selection.

Interventions

DIETARY_SUPPLEMENTSolution ingestion

Two ingestion modalities will be attributed (participant is blinded) in random order: a placebo and a glucose solution. The placebo contains water and a non-caloric sweetener (stevia) in order to reproduce the taste of the glucose solution. The glucose solution contains 6% glucose per volume, labelled with 13C. Both solutions will be administered in 8 doses: a bolus (333 mL) at rest, 30 minutes before the start of exercise, 167 mL immediately before exercise, 167 mL every 15 minutes during arm cranking, 125 mL immediately before concentric or eccentric pedalling and at 15 and 25 minutes of this last exercise period. In total, 1250 mL of solution will be administered during the experimental protocol.

BEHAVIORALConstant load arm cranking

The participants will perform 45 minutes of arm cranking on a specialized ergometer at a power output corresponding to 30% of their concentric cycling VO2max, previously measured.

Subjects will be asked, twice, to provide a forced expiration into a 10 mL plastic tube in order to collect a sample expired gases. This procedure will be done immediately before blood sampling and ingestion of the solution.

A mouthpiece and nose plug will be placed on the subject and expired gases will be analyzed by a metabolic cart during 3 minutes. This procedure will be done immediately before expired gas collection, blood sampling and ingestion of the solution.

PROCEDUREBlood sampling

A catheter will be inserted in an antecubital vein and a saline solution will be continuously perfused to maintain vein open. 10 mL of blood will be collected immediately before ingesting the solution for a total of 80 mL.

BEHAVIORALMeasure of maximal voluntary contraction force production

Maximal voluntary bilateral knee extensions (3 trials of 3-4 seconds each) will be performed on a chair equipped with force sensors to measure peak force production. These measurements will be done before the first ingestion, immediately before exercise, during the transition between arm cranking and concentric or eccentric cycling, and at the end of the exercise protocol.

DIAGNOSTIC_TESTMeasure of muscle electrical activity (EMG)

Surface electrodes will be placed on the biceps and quadriceps to measure EMG throughout the exercise protocol.

DIAGNOSTIC_TESTMeasure of central and cutaneous temperatures

Wireless sensors will be placed on the skin of the arm, chest, back, abdomen, thigh and calf using adhesive tape. A wireless thermometric pill will be ingested the morning of the experiment. These will allow the measurement of skin and central temperatures throughout the exercise protocol.

DIAGNOSTIC_TESTMeasure of perceived exertion, pain perception and affective response

100 points scales (CR100) will be used to measure perceived exertion and pain perception immediately before ingesting the gas sampling. At the same time, affective responses will be assessed using the Feeling scale.

PROCEDUREMeasure of sweat and urine production

Sweat production and sampling will be performed by measuring body weight before and after exercise, after voiding the bladder. Mass loss through the urine and gases will be accounted for in order to compute sweat production. A sweat sample will be collected using a cotton gauze placed into a plastic collector affixed in the upper back of the participants. A urine sample will be taken from the urine collected at the end of the exercise period. Urine and sweat volumes along with respective urea concentrations will be used to compute protein oxidation during exercise.

Sponsors

Université de Montréal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Opaque bottles to administer beverages with similar sweet taste.

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Low alcohol consumption (\<3 drinks/week) * Non-smokers * Not regularly taking medication for a known pathology * Regularly practices endurance sports (cycling, running, etc.)

Exclusion criteria

* Intolerant to glucose (according to WHO standards) * Musculoskeletal injury or illness affecting exercise performance * Failure to respect protocol guidelines (diet, exercise prior to experimentation, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Exogenous glucose oxidationAverage over the 35 minutes of eccentric or concentric exerciseMeasured by indirect respiratory calorimetry combined with tracer techniques.
Maximal voluntary force productionChange between baseline and end of exerciseMeasured using isometric bilateral knee extensions
Central and skin temperatureAverage over the 35 minutes of eccentric or concentric exerciseMeasured using a thermometric pill and skin-surface electrodes
Perceived exertionAverage over the 35 minutes of eccentric or concentric exerciseMeasured using a Category Ratio scale on 100 points (CR100), 0 signifies no exertion and 100 being maximal effort.

Secondary

MeasureTime frameDescription
Total carbohydrate, fat and protein oxidationAverage over the 35 minutes of eccentric or concentric exerciseMeasured by indirect respiratory calorimetry corrected for urea excretion in sweat and urine
Blood insulin concentrationFor 0 minutes corresponds to the beginning of exercise, at -31, -1, 14, 29, 44, 49, 59 and 69 minutesBlood is sampled using a venous catheter over about 60 seconds. Following centrifugation to extract the plasma, a small sample is used to measure insulin concentration.
Affective responseAverage over the 35 minutes of eccentric or concentric exerciseFeeling scale, ranging from -5 to +5, reporting the mood (Hardy & Rejeski, 1989). -5 corresponds to very bad and +5 to very good.
Pain perception: VASAverage over the 35 minutes of eccentric or concentric exerciseVisual analogue pain scale of 25 cm, relative distance converted to score on 100 points. Higher values correspond to greater pain sensation.
Blood glucose concentrationFor 0 minutes corresponds to the beginning of exercise, at -31, -1, 14, 29, 44, 49, 59 and 69 minutesBlood is sampled using a venous catheter over about 60 seconds. Following centrifugation to extract the plasma, a small sample is used to measure glucose concentration.
Blood free-fatty acid concentrationFor 0 minutes corresponds to the beginning of exercise, at -31, -1, 14, 29, 44, 49, 59 and 69 minutesBlood is sampled using a venous catheter over about 60 seconds. Following centrifugation to extract the plasma, a small sample is used to measure free-fatty acid concentration.
Blood lactate concentrationFor 0 minutes corresponds to the beginning of exercise, at -31, -1, 14, 29, 44, 49, 59 and 69 minutesBlood is sampled using a venous catheter over about 60 seconds. Following centrifugation to extract the plasma, a small sample is used to measure lactate concentration.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026